Back to Search
Start Over
Spontaneous rectus sheath hematoma during rivaroxaban therapy.
- Source :
- Indian Journal of Pharmacology; May/Jun2014, Vol. 46 Issue 3, p339-340, 2p
- Publication Year :
- 2014
-
Abstract
- Rivaroxaban is an oral anticoagulant agent that directly inhibits Factor Xa and interrupts both the intrinsic and extrinsic pathway of the coagulation cascade and is currently indicated for use in patients for atrial fibrillation and prophylaxis of deep venous thrombosis. The present case reports of spontaneous rectus sheath hematoma during rivaroxaban therapy for atrial fibrillation in a 75-year-old woman. [ABSTRACT FROM AUTHOR]
- Subjects :
- HEMATOMA
RIVAROXABAN
ANTICOAGULANTS
ATRIAL fibrillation
THROMBOSIS
Subjects
Details
- Language :
- English
- ISSN :
- 02537613
- Volume :
- 46
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- Indian Journal of Pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 96179248
- Full Text :
- https://doi.org/10.4103/0253-7613.132193